{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T19:12:39Z","timestamp":1778094759606,"version":"3.51.4"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/bor.0b013e3283470f23","type":"journal-article","created":{"date-parts":[[2011,4,26]],"date-time":"2011-04-26T07:52:41Z","timestamp":1303804361000},"page":"339-345","source":"Crossref","is-referenced-by-count":54,"title":["How to measure disease activity in axial spondyloarthritis?"],"prefix":"10.1097","volume":"23","author":[{"given":"Pedro","family":"Machado","sequence":"first","affiliation":[]},{"given":"D\u00e9sir\u00e9e","family":"van der Heijde","sequence":"additional","affiliation":[]}],"member":"276","reference":[{"key":"R1-5-20210128","first-page":"2286","article-title":"A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index","volume":"21","author":"Garrett","year":"1994","journal-title":"J Rheumatol"},{"key":"R2-5-20210128","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/rheumatology\/keh595","article-title":"Measuring disease activity in ankylosing spondylitis: patient and physician have different perspectives","volume":"44","author":"Spoorenberg","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"R3-5-20210128","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.20233","article-title":"The influence of peripheral arthritis on disease activity in ankylosing spondylitis patients as measured with the Bath Ankylosing Spondylitis Disease Activity Index","volume":"51","author":"Heuft-Dorenbosch","year":"2004","journal-title":"Arthritis Rheum"},{"key":"R4-5-20210128","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1136\/ard.2008.099226","article-title":"Comparison of the Bath Ankylosing Spondylitis Disease Activity Index and a modified version of the index in assessing disease activity in patients with ankylosing spondylitis without peripheral manifestations","volume":"68","author":"Song","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R5-5-20210128","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1136\/ard.2005.042630","article-title":"An international study on starting tumour necrosis factor-blocking agents in ankylosing spondylitis","volume":"65","author":"Pham","year":"2006","journal-title":"Ann Rheum Dis"},{"key":"R6-5-20210128","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/ard.2008.094870","article-title":"Development of an ASAS-endorsed disease activity score (ASDAS) in patients with ankylosing spondylitis","volume":"68","author":"Lukas","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R7-5-20210128","first-page":"980","article-title":"Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis","volume":"26","author":"Spoorenberg","year":"1999","journal-title":"J Rheumatol"},{"key":"R8-5-20210128","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1136\/ard.2008.100826","article-title":"ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis","volume":"68","author":"Van der Heijde","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"R9-5-20210128","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1002\/art.21209","article-title":"The comparative effectiveness of tumor necrosis factor-blocking agents in patients with rheumatoid arthritis and patients with ankylosing spondylitis: a six-month, longitudinal, observational, multicenter study","volume":"52","author":"Heiberg","year":"2005","journal-title":"Arthritis Rheum"},{"key":"R11-5-20210128","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/ard.2010.138594","article-title":"Ankylosing Spondylitis Disease Activity Score (ASDAS): defining cut-off values for disease activity states and improvement scores","volume":"70","author":"Machado","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"R12-5-20210128","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1136\/ard.2009.111187","article-title":"Responsiveness of the Ankylosing Spondylitis Disease Activity Score (ASDAS) and clinical and MRI measures of disease activity in a 1-year follow-up study of patients with axial spondyloarthritis treated with tumour necrosis factor alpha inhibitors","volume":"69","author":"Pedersen","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R13-5-20210128","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1756-185X.2010.01537.x","article-title":"Discrimination ability of ASDAS estimating disease activity status in patients with ankylosing spondylitis","volume":"13","author":"Nas","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"R14-5-20210128","first-page":"752","article-title":"Active disease requiring TNF-alpha-antagonist therapy can be well discriminated with different ASDAS sets: a prospective, follow-up of disease activity assessment in ankylosing spondylitis","volume":"28","author":"Aydin","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"R15-5-20210128","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1136\/ard.2010.129726","article-title":"Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis?","volume":"69","author":"Eder","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R20-5-20210128","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1136\/ard.2009.120139","article-title":"Comparison of a high sensitivity and standard C reactive protein measurement in patients with ankylosing spondylitis and nonradiographic axial spondyloarthritis","volume":"69","author":"Poddubnyy","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"R22-5-20210128","first-page":"198","article-title":"The OMERACT filter for outcome measures in rheumatology","volume":"25","author":"Boers","year":"1998","journal-title":"J Rheumatol"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0b013e3283470f23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T23:01:35Z","timestamp":1620946895000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002281-201107000-00005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0b013e3283470f23","relation":{},"ISSN":["1040-8711"],"issn-type":[{"value":"1040-8711","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]}}}